|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.24 HKD | -1.90% |
|
+1.69% | +3.22% |
| Feb. 03 | Hansoh Pharmaceutical Sells HK$4.68 Billion Convertible Bonds | MT |
| Jan. 26 | Hansoh Pharmaceutical Plans Nearly HK$4.7 Billion Zero-Coupon Convertible Bond Issue | MT |
| Capitalization | 203B 230B 29.4B 24.78B 22.68B 21.55B 39.95B 2,668B 41.3B 261B 104B 1,283B 110B 108B 4,507B | P/E ratio 2025 * |
39.3x | P/E ratio 2026 * | 37x |
|---|---|---|---|---|---|
| Enterprise value | 177B 200B 25.6B 21.57B 19.74B 18.76B 34.78B 2,323B 35.96B 228B 90.91B 1,117B 96B 94.02B 3,924B | EV / Sales 2025 * |
12x | EV / Sales 2026 * | 10.8x |
| Free-Float |
18.75% | Yield 2025 * |
0.92% | Yield 2026 * | 0.97% |
| 1 day | -1.90% | ||
| 1 week | +1.69% | ||
| Current month | -3.52% | ||
| 1 month | -8.37% | ||
| 3 months | +1.42% | ||
| 6 months | +3.16% | ||
| Current year | +3.22% |
| 1 week | 35.6 |  | 38.38 |
| 1 month | 35.28 | | 44.22 |
| Current year | 35.28 | | 44.22 |
| 1 year | 17.1 | | 44.22 |
| 3 years | 9.41 | | 44.22 |
| 5 years | 9.41 | | 44.22 |
| 10 years | 9.41 | | 46.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hui Juan Zhong
CEO | Chief Executive Officer | 65 | 2015-12-01 |
Leong Yin Lee
SEC | Corporate Secretary | 37 | 2025-12-25 |
Sheng Li Zhong
SEC | Corporate Secretary | 58 | 2018-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Hui Juan Zhong
CHM | Chairman | 65 | 2015-12-01 |
Ai Feng Lyu
BRD | Director/Board Member | 49 | 2016-03-10 |
Yu An Sun
BRD | Director/Board Member | 39 | 2015-12-01 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.90% | +1.69% | +115.26% | +143.40% | 29.4B | |
| -0.96% | -8.30% | +17.37% | +194.16% | 909B | |
| +1.05% | +2.73% | +54.27% | +48.54% | 580B | |
| -0.70% | +1.74% | +15.15% | +45.27% | 390B | |
| +0.38% | -0.20% | +22.73% | +28.22% | 370B | |
| -0.41% | +2.77% | +25.34% | +52.42% | 305B | |
| +0.31% | +6.61% | +26.28% | +30.49% | 314B | |
| +1.84% | +0.83% | +37.87% | +9.89% | 296B | |
| +0.39% | +9.64% | -47.46% | -38.09% | 216B | |
| +0.53% | +0.10% | +23.57% | +51.17% | 197B | |
| Average | +0.04% | +1.06% | +29.04% | +56.55% | 360.68B | |
| Weighted average by Cap. | +0.34% | -0.53% | +23.99% | +74.11% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 14.69B 16.61B 2.12B 1.79B 1.64B 1.56B 2.89B 193B 2.99B 18.9B 7.55B 92.71B 7.97B 7.8B 326B | 16.01B 18.11B 2.32B 1.95B 1.79B 1.7B 3.15B 210B 3.25B 20.61B 8.23B 101B 8.69B 8.51B 355B |
| Net income | 5.01B 5.66B 725M 611M 559M 531M 985M 65.75B 1.02B 6.44B 2.57B 31.61B 2.72B 2.66B 111B | 5.41B 6.12B 783M 660M 604M 574M 1.06B 71.03B 1.1B 6.96B 2.78B 34.15B 2.94B 2.87B 120B |
| Net Debt | -26.27B -29.71B -3.8B -3.2B -2.93B -2.79B -5.17B -345B -5.34B -33.81B -13.5B -166B -14.25B -13.96B -583B | -30.72B -34.74B -4.44B -3.75B -3.43B -3.26B -6.04B -403B -6.24B -39.53B -15.78B -194B -16.67B -16.33B -681B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-02-12 | 37.24 $ | -1.90% | 7,415,061 |
| 26-02-11 | 37.96 $ | +1.12% | 5,626,892 |
| 26-02-10 | 37.54 $ | +1.13% | 9,754,933 |
| 26-02-09 | 37.12 $ | +1.75% | 10,162,390 |
| 26-02-06 | 36.48 $ | -0.38% | 7,866,598 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 3692 Stock
Select your edition
All financial news and data tailored to specific country editions
